BF Biosciences Limited (PSX:BFBIO)

BF Biosciences Revenue

BF Biosciences had revenue of 2.14B PKR in the quarter ending March 31, 2026, with 42.32% growth. This brings the company's revenue in the last twelve months to 8.86B, up 78.71% year-over-year. In the fiscal year ending June 30, 2025, BF Biosciences had annual revenue of 5.84B with 59.55% growth.

• Revenue (ttm): 8.86B
• Revenue Growth: +78.71%
• P/S Ratio: 1.37
• Revenue / Employee: 16.56M
• Employees: 535
• Market Cap: 12.10B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	5.84B	2.18B	59.55%
Jun 30, 2024	3.66B	1.85B	102.19%
Jun 30, 2023	1.81B	288.82M	18.99%
Jun 30, 2022	1.52B	-234.10M	-13.34%
Jun 30, 2021	1.75B	1.13B	179.30%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 8, 2026

Data Sources Report a data error